Integrated Wealth Concepts’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143K Buy
25,209
+353
+1% +$1.73K ﹤0.01% 2276
2026
Q1
$107K Buy
24,856
+3,616
+17% +$20.1K ﹤0.01% 2172
2025
Q4
$190K Sell
21,240
-3,370
-14% -$20.9K ﹤0.01% 1537
2025
Q3
$91.1K Buy
24,610
+4,419
+22% +$12K ﹤0.01% 1923
2025
Q2
$39.4K Buy
+20,191
New +$42.1K ﹤0.01% 1873

Other funds holding NUVB

Integrated Wealth Concepts's NUVB Position: Q2 2026 in Review

Integrated Wealth Concepts increased its Nuvation Bio (NUVB) stake by 1.4% in Q2 2026, buying an estimated $1.73K and bringing the position to 25,209 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Integrated Wealth Concepts first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $190K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Integrated Wealth Concepts held 25,209 shares of Nuvation Bio worth $143K as of Q2 2026.
  • Integrated Wealth Concepts bought 353 Nuvation Bio shares in Q2 2026, an estimated $1.73K.
  • Nuvation Bio made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #2276 holding.
  • Integrated Wealth Concepts first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • Integrated Wealth Concepts's Nuvation Bio position peaked at $190K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.